In our study, we demonstrate the anti-fibrotic potential of NCI-41356 as a new chemical inhibitor of HSPB5/SMAD4 interaction in a bleomycin-induced pulmonary fibrosis model. This evidence concerns the gene CRYAB and pulmonary fibrosis.